HemoGenyx Pharmaceuticals Plc (HOPHF)
2.33
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
HemoGenyx Pharmaceuticals Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Silence Therapeutics Plc | 8.297M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 3.020M |
| Mereo BioPharma Group Plc | 1.811M |
| Compass Pathways Plc | 29.23M |